Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Dublin, Dec. 16, 2016 -- Research and Markets has announced the addition of the "Diabetes Diagnostics - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Diabetes Diagnostics in US$ Thousand by the following Product Segments:
- Continuous Glucose Monitoring (CGM) Systems
- HbA1c Testing Devices
- Blood Glucose Monitoring Devices
The report profiles 58 companies including many key and niche players such as
- Abbott Diabetes Care, Inc. (US)
- Acon Laboratories, Inc. (US)
- AgaMatrix, Inc. (US)
- Alere Inc. (US)
- Animas Corporation (US)
- Apex Biotechnology Corporation (Taiwan)
- ARKRAY, Inc. (Japan)
- Ascensia Diabetes Care Holdings AG (Switzerland)
- A.Menarini Diagnostics Ltd. (UK)
- B. Braun Melsungen AG (Germany)
- Becton, Dickinson and Company (US)
- Bayer Healthcare Diabetes Care (US)
- Beckman Coulter, Inc. (US)
- Bio-Rad Laboratories (US)
- BIONIME Corporation (Taiwan)
- Diazyme Laboratories Inc. (US)
- Dexcom, Inc. (US)
- EKF Diagnostics Holdings Plc (UK)
- HemoCue® AB (Sweden)
- Infopia Co., Ltd. (South Korea)
- LifeScan, Inc. (US)
- Medtronic MiniMed, Inc. (US)
- Nova Biomedical Corporation (US)
- PTS Diagnostics (US)
- Roche Diagnostics (Switzerland)
- Sanofi S.A. (France)
- Sanwa Kagaku Kenkyusho Co, Ltd. (Japan)
- Siemens Healthineers (Germany)
- Taidoc Technology Corporation (Taiwan)
- Tandem Diabetes Care, Inc. (US)
- Terumo Corporation (Japan)
- Tosoh Bioscience, Inc. (US)
- Trinity Biotech plc (Ireland)
- Trividia Health, Inc. (US)
- Ypsomed AG (Switzerland)
Key Topics Covered:
1. Industry Overview
2. Competition
3. Market Trends, Issues & Drivers
4. Diabetes Diagnostics Innovations & Advancements
5. Product Overview
6. Product Launches
7. Recent Industry Activity
8. Focus On Select Global Players
9. Global Market Perspective
Total Companies Profiled: 58 (including Divisions/Subsidiaries 75)
- The United States (35)
- Canada (1)
- Japan (4)
- Europe (23)
- - France (2)
- - Germany (4)
- - The United Kingdom (8)
- - Italy (1)
- - Rest of Europe (8)
- Asia-Pacific (Excluding Japan) (10)
- Middle-East (2)
For more information about this report visit http://www.researchandmarkets.com/research/w859zk/diabetes
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics, Endocrinology
